72.11.Z - Research and experimental development on biotechnology
62.0 - Computer programming, consultancy and related activities
63.9 - Other information service activities
71.20 - Technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.3 - Rental and leasing of other machinery, equipment and tangible goods
78.30.Z - Other human resources provision
82.9 - Business support service activities n.e.c.
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 1,3 | 1 | -2,8 | -379,3 |
EBITDA | 1,3 | 1 | -2,8 | -379,3 |
Short time liabilities | 0,2 | 0,2 | 0,2 | 0 |
Equity capital | 14,5 | 15,5 | 12,6 | -18,2 |
Operating profit (EBIT) | 1,3 | 1 | -2,8 | -379,3 |
Assets | 14,7 | 15,7 | 12,8 | -17,9 |
Net profit (loss) | 1,2 | 0,9 | -2,8 | -407,1 |
Cash | 13,4 | 14,3 | 12,6 | -12,5 |
Net income from sale | 15,5 | 7,5 | 0 | -100 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,2 | 0 |
Working assets | 14,7 | 15,7 | 12,8 | -17,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 8,4 | 5,9 | -22,2 | -28,1 |
Equity capital to total assets | 98,6 | 98,7 | 98,4 | -0,3 |
Gross profit margin | 8,7 | 13,4 | 4,7 | |
EBITDA Margin | 8,7 | 13,4 | 4,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5 | 10 | 2 147 483 648 | 2 147 483 638 |
Current financial liquidity indicator | 73.7061538696289 | 78.27865600585938 | 64.23865509033203 | -14,1 |
Net dept to EBITDA | -9.967547416687012 | -14.264276504516602 | 4.471057891845703 | 18,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane